AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildalib M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Libramed Pharmaceuticals Private Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildalib M 500mg/50mg Tablet

Combiflex DM 500mg/50mg tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Combiflex DM 500mg/50mg may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a healthy diet and regular physical activity. Dosage is personalized based on individual health status, blood glucose readings, and existing medications. Consuming the tablet with food minimizes gastrointestinal upset. Consistent daily dosing, at the same time each day, maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Maintaining controlled blood sugar levels through this medication helps mitigate future complications. Continued commitment to the prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; understanding its symptoms and management is essential. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any history of hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Potential drug interactions necessitate complete disclosure of all medications to ensure patient safety. Alcohol should be avoided due to its potential to induce hypoglycemia. Your physician will monitor renal function and blood sugar throughout treatment.

Primary Ingredients of Vildalib M 500mg/50mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Vildalib M 500mg/50mg Tablet

Managing Type 2 Diabetes

Major Benefits of Vildalib M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Vildalib M 500mg/50mg Tablet should be administered with a meal.

Common Side effects of Vildalib M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildalib M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg/50mg Vildalib M Tablet whole; do not crush, chew, or break it. Administer this medicine with a meal.

How Vildalib M 500mg/50mg Tablet works:

Metformin and vildagliptin, at dosages of 500mg and 50mg respectively, are combined in the Vildalib M tablet.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Vildalib M 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildalib M 500mg/50mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildalib M 500mg/50mg Tablet while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildalib M 500mg/50mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Use of Vildalib M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Vildalib M 500mg/50mg Tablet :

Should you forget a Vildalib M 500mg/50mg Tablet dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Vildalib M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vildalib M 500mg/50mg Tablet

Vildalib M 500mg/50mg tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildalib M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Vildalib M 500mg/50mg Tablets are contraindicated in patients allergic to any component or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildalib M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildalib M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue use and seek immediate medical attention.
Prolonged use of Vildalib M 500mg/50mg Tablet can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildalib M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if you also take insulin or sulphonylurea). Report any persistent side effects to your physician.
Vildalib M 500mg/50mg Tab...
62
MRP 72
14% off